Must-ask questions for an obesity referral partner
By 2030, half the U.S. population is projected to be obese, and nearly 25% will be severely obese, according to a Harvard study. For medical practice leaders, this carries risks to your organization’s bottom line. It will be crucial to manage the impact that obesity and related issues — including diabetes and cardiovascular disease — have on the fastest-growing outpatient procedures for spine, orthopedics and cardiology specialists.
In the following research paper, 20Lighter explains how an obesity-focused referral partner can be a powerful tool in improving patient outcomes and your practice’s bottom line. The key, they have found through their research, is in finding the right partner.
Written By
Jessica Barnes, PhD, is the CEO and co-founder of 20Lighter, a groundbreaking scientifically based obesity and cardiometabolic intervention. She earned her PhD in molecular neuroscience from the University of Illinois at Urbana-Champaign. She was a fellow in the Department of Pediatric Neuro-oncology at the Dana-Farber Cancer Institute and Children’s Hospital Boston under the mentorship of Judah Folkman, MD, the father of angiogenesis. With a background in clinical research, biotech/healthcare investment banking and venture capital, she has a passion for health and helping individuals and businesses be their best.